Article
Solriamfetol enhances alertness and cognitive performance in mice
2025-01-02
Abstract excerpt
Solriamfetol [(R)-2-amino-3-phenylpropylcarbamate hydrochloride], a phenylalanine derivative initially developed as potential antidepressant, was shown by our group in 2009 to have potent, dose-dependent wake-promoting activity in mice. Solriamfetol (Sunosi ® ) is used since 2019 to counteract excessive daytime sleepiness (EDS) in patients with narcolepsy and obstructive sleep apnea (OSA). It has several advantag...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 3f931c65-489e-53c9-86db-d4348dd0ee1c
- DOI
- 10.1101/2025.01.02.631072
